-
DNA Repair in Huntington’s Disease: Not Up to Par?
Latest News
-
Unlocking the Mind’s Eye: How Huntington’s Disease Changes How We See and Process the World
For many with Huntington’s disease, recognising faces, navigating familiar places, or reading can be difficult. Scientists studied how and when HD affects how the brain processes what we see—crucial research to improve support for people with HD.
-
Raptor announces results of cysteamine trial for Huntington's disease
Raptor Pharmaceuticals announces intermediate results from a long-term study of cysteamine in Huntington's disease
-
Sleep, cilia and HD
New studies shed some light on the function of sleep in animals, with interesting implications for HD research
-
Huntington's Disease Therapeutics Conference 2014: day 3
Biomarkers and preparing for trials: the third & final day of the 2014 Huntington's Disease Therapeutics Conference
-
Huntington's Disease Therapeutics Conference 2014: day 2
Cells, circuits and systems: day 2 of the 2014 HD Therapeutics conference
-
Huntington's Disease Therapeutics Conference 2014: day 1
HDBuzz reports from the opening day of science sessions at the 2014 HD Therapeutics Conference in Palm Springs.
-
Prana announces results of Reach2HD trial of PBT2 for Huntington's disease
Results are in for a clinical trial testing the drug PBT2 for HD. Are the claims in the announcement justified?
-
Does high-dose creatine "slow the onset" of Huntington's Disease?
A new study claims that high-dose creatine "slows the onset of Huntington Disease". How much hope and how much hype?
-
Joint HDBuzz Prizewinner: Yeast studies suggest a new way to protect cells from 'oxidative damage'
Researchers identify Gpx1, a protein that may be protective in HD. An existing drug can mimic its antioxidant effect.
-
Joint HDBuzz Prizewinner: Pennies for your neurons — copper’s bad influence on Huntington’s disease
There is copper in your brain! Check out how copper and the Huntington’s disease protein are partners in crime.
-
Could a 'brain shuttle' get Huntington's disease drugs to where they're needed?
Roche's 'brain shuttle' sneaks drugs past the blood-brain barrier. Could it work for HD gene silencing drugs?